New York Bill: A 9060

Bill Summary

A9060 amends education and insurance law so that regulations for administering immunizations can be based not only on CDC’s ACIP recommendations but also on guidance from the American Academy of Pediatrics, American Academy of Family Physicians, American College of Obstetricians and Gynecologists, American College of Physicians, New York’s Immunization Advisory Council, and any interstate body that reviews immunization coverage and access. It authorizes physicians to issue patient‑specific or non‑patient‑specific orders to pharmacists for a wide list of vaccines (influenza from age 2; many adult vaccines from age 18) and allows pharmacists to administer additional vaccines recommended by those entities when the Health Commissioner determines they are safe for pharmacist administration and needed to prevent prevalent communicable diseases, while insurance law is updated so plans must cover all such recommended immunizations.

Why It Matters to MAHA

The MAHA Movement opposes this bill because it expands the range of institutions that can drive New York’s vaccine agenda and effectively creates an open‑ended pipeline for new recommended shots, administered widely under standing orders, instead of narrowing mandates or strengthening opt‑outs. By empowering pharmacists to deliver more vaccines and tying insurance coverage to a broadened set of professional‑body recommendations, A9060 pushes New York further toward a system‑driven, high‑throughput vaccination model that runs counter to MAHA’s focus on strict limits, deeper safety scrutiny, and medical freedom.